WALL TOWNSHIP, N.J., April 9, 2024 /PRNewswire/ — Manasquan Bank is proud to announce the appointment of Andrew Drechsler to its Board of Directors, effective April 24, 2024. Mr. Drechsler is an accomplished financial and operational executive with extensive experience in both public and…
Month: April 2024
WALL TOWNSHIP, N.J., April 9, 2024 /PRNewswire/ — Manasquan Bank is proud to announce the appointment of Andrew Drechsler to its Board of Directors, effective April 24, 2024. Mr. Drechsler is an accomplished financial and operational executive with extensive experience in both public and…
DALLAS, April 9, 2024 /PRNewswire/ — Jacobs (NYSE:J) plans to release its fiscal second quarter 2024 earnings results before market open on Tuesday, May 7, 2024, and will host a conference call at 10:00 a.m. ET, during which management will make a presentation focusing on the company’s…
DALLAS, April 9, 2024 /PRNewswire/ — Jacobs (NYSE:J) plans to release its fiscal second quarter 2024 earnings results before market open on Tuesday, May 7, 2024, and will host a conference call at 10:00 a.m. ET, during which management will make a presentation focusing on the company’s…
LOS ANGELES, April 9, 2024 /PRNewswire/ — B. Riley Financial, Inc. (NASDAQ: RILY) (“B. Riley” or the “Company”) has declared cash dividends on its 6.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: RILYP) and its 7.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ:…
LOS ANGELES, April 9, 2024 /PRNewswire/ — B. Riley Financial, Inc. (NASDAQ: RILY) (“B. Riley” or the “Company”) has declared cash dividends on its 6.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: RILYP) and its 7.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ:…
Randomized Controlled Trial Targets Residual Cancer Cells during Brain Surgery with Implant Delivering Radiation, Aiming to Advance Local Control TEMPE, Ariz., April 9, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving…
Randomized Controlled Trial Targets Residual Cancer Cells during Brain Surgery with Implant Delivering Radiation, Aiming to Advance Local Control TEMPE, Ariz., April 9, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving…
CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ — Factor Bioscience Inc. (“Factor”), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, today announced the addition of three members to its translational science team, which will…
CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ — Factor Bioscience Inc. (“Factor”), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, today announced the addition of three members to its translational science team, which will…